Corvus Pharmaceuticals Inc sell StockNews.com
Start price
28.09.24
/
50%
€4.51
Target price
28.09.25
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 28.09.25. The prediction end date can be changed by StockNews_com at any time.Performance without dividends (%)
Name | 1w |
---|---|
Corvus Pharmaceuticals Inc | - |
iShares Core DAX® | 3.523% |
iShares Nasdaq 100 | 1.026% |
iShares Nikkei 225® | -0.063% |
iShares S&P 500 | 0.557% |
Comments by StockNews_com for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CRVS provided by MarketBeat
Stopped prediction by StockNews_com for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.92
03.04.23
03.04.23
-
03.04.24
03.04.24
81.96%
04.04.24
04.04.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.65
26.03.23
26.03.23
-
26.03.24
26.03.24
144.58%
27.03.24
27.03.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.68
18.03.23
18.03.23
-
18.03.24
18.03.24
157.58%
19.03.24
19.03.24